Differential inhibitory effect of L‐lysine on renal accumulation of 67Cu‐labelled F(ab′)2 fragments in mice

The basic amino acid L‐lysine was administered to mice in an attempt to circumvent unwanted renal accumulation of 67Cu‐labelled F(ab′)2 fragments derived from the anti‐NCAM IgG1, SEN7 and anti‐CEA IgG1 monoclonal antibody (MAb)35. In control experiments, significant renal uptake of both 67Cu‐labelled F(ab′)2 fragments was observed, radiolabel being primarily localised to proximal tubules in the renal cortex. Following optimised L‐lysine dosing protocols, renal uptake of 67Cu‐MAb35 F(ab′)2 was inhibited by up to 42%. Surprisingly, little inhibition (<10%) of 67Cu‐SEN7 F(ab′)2 uptake was observed. Experiments to investigate this differential inhibition indicated that inhibition of MAb35 F(ab′)2 uptake was relatively short‐lived (approx. 6 hr), whilst no apparent differences were found in blood clearance rates between either 67Cu‐F(ab′)2 fragment. L‐lysine administration caused a significant diuresis with high levels of intact 67Cu‐labelled SEN7 and MAb35 F(ab′)2 appearing in the urine, possibly due to blockade of renal uptake and lysine‐induced increases in glomerular membrane permeability. Iso‐electric focusing studies failed to identify any charge differences between the 67Cu‐labelled F(ab′)2 fragments, although a cathodal migration of all 67Cu‐labelled samples, presumably due to the net positive charge conferred by addition of 67Cu2+ ions, was observed. Our results demonstrate that in addition to net charge, other unidentified characteristics may influence renal accumulation of radiometal‐labelled F(ab′)2 fragments and their inhibition by L‐lysine. Int. J. Cancer 72:522–529, 1997. © 1997 Wiley‐Liss, Inc.

[1]  H. Amstutz,et al.  Tumor uptake and metabolism of copper-67-labeled monoclonal antibody chCE7 in nude mice bearing neuroblastoma xenografts. , 1997, Journal of nuclear medicine : official publication, Society of Nuclear Medicine.

[2]  M. Welch,et al.  Comparison of four bifunctional chelates for radiolabeling monoclonal antibodies with copper radioisotopes: biodistribution and metabolism. , 1996, Bioconjugate chemistry.

[3]  Wendy S. Becker,et al.  Reduction of renal uptake of monoclonal antibody fragments by amino acid infusion. , 1996, Journal of nuclear medicine : official publication, Society of Nuclear Medicine.

[4]  I. Bernstein,et al.  Comparative metabolism and retention of iodine-125, yttrium-90, and indium-111 radioimmunoconjugates by cancer cells. , 1996, Cancer research.

[5]  P. Schubiger,et al.  Vehicles, chelators, and radionuclides: choosing the "building blocks" of an effective therapeutic radioimmunoconjugate. , 1996, Bioconjugate chemistry.

[6]  G. Snow,et al.  Monoclonal antibodies labeled with rhenium-186 using the MAG3 chelate: relationship between the number of chelated groups and biodistribution characteristics. , 1996, Journal of nuclear medicine : official publication, Society of Nuclear Medicine.

[7]  N. Kotite,et al.  Lysine reduces renal accumulation of radioactivity associated with injection of the [177Lu]alpha-[2-(4-aminophenyl) ethyl]-1,4,7,10-tetraaza-cyclodecane-1,4,7,10-tetraacetic acid-CC49 Fab radioimmunoconjugate. , 1995, Cancer research.

[8]  Wendy S. Becker,et al.  Reduction of the renal uptake of radiolabeled monoclonal antibody fragments by cationic amino acids and their derivatives. , 1995, Cancer research.

[9]  P. Cutler,et al.  Preparation, biodistribution and dosimetry of copper-64-labeled anti-colorectal carcinoma monoclonal antibody fragments 1A3-F(ab')2. , 1995, Journal of nuclear medicine : official publication, Society of Nuclear Medicine.

[10]  R. Owens,et al.  Improved tumor targeting with chemically cross-linked recombinant antibody fragments. , 1994, Cancer research.

[11]  P. Schubiger,et al.  Preclinical evaluation of 67Cu-labeled intact and fragmented anti-colon carcinoma monoclonal antibody MAb35. , 1993, Cancer research.

[12]  Jerry R. Williams,et al.  Assessment of radiolabeled stabilized F(ab')2 fragments of monoclonal antiferritin in nude mouse model. , 1993, Journal of nuclear medicine : official publication, Society of Nuclear Medicine.

[13]  J. Baak,et al.  Kinetics and tissue distribution of the radiolabeled chimeric monoclonal antibody MOv18 IgG and F(ab')2 fragments in ovarian carcinoma patients. , 1993, Cancer research.

[14]  V. Torchilin,et al.  Biodistribution of anti-CEA F(ab')2 fragments conjugated with chelating polymers: influence of conjugate electron charge on tumor uptake and blood clearance. , 1993, Nuclear medicine and biology.

[15]  F. Lang,et al.  Hepatic regulation of renal function , 1992, Experimental physiology.

[16]  M. Nedelman,et al.  Enhanced kidney clearance with an ester-linked 99mTc-radiolabeled antibody Fab'-chelator conjugate. , 1990, Bioconjugate chemistry.

[17]  L. Racusen,et al.  Effects of lysine and other amino acids on kidney structure and function in the rat. , 1985, The American journal of pathology.

[18]  C. Mogensen,et al.  Studies on renal tubular protein reabsorption: partial and near complete inhibition by certain amino acids. , 1977, Scandinavian journal of clinical and laboratory investigation.

[19]  H. Amstutz,et al.  Cellular processing of copper-67-labeled monoclonal antibody chCE7 by human neuroblastoma cells. , 1995, Cancer research.

[20]  G. Borm,et al.  Decreased kidney uptake of technetium-99m-labelled Fab' fragments in ovarian carcinoma bearing nude mice using a cleavable chelator. , 1994, Nuclear medicine and biology.

[21]  R. Stahel,et al.  A comparison of 67Cu‐ and 131I‐labelled forms of monoclonal antibodies SEN7 and SWA20 directed against small‐cell lung cancer , 1994, International journal of cancer. Supplement = Journal international du cancer. Supplement.

[22]  T Takahashi,et al.  Prognostic significance of p53 mutations and 3p deletions in primary resected non-small cell lung cancer. , 1993, Cancer research.

[23]  P. Bunn,et al.  Determination of the true immunoreactive fraction of monoclonal antibodies after radiolabeling. , 1986, Methods in enzymology.

[24]  M. Trucco,et al.  1 – Determination of Equilibrium Binding Parameters of Monoclonal Antibodies Specific for Cell Surface Antigens , 1981 .